MedStar Georgetown University Medical Center — Washington D.C., District of Columbia

MedStar Georgetown University Medical Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MedStar Georgetown University Medical Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL).

Sponsors: Takeda.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Georgetown University Medical Center?

MedStar Georgetown University Medical Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Georgetown University Medical Center conducted?

MedStar Georgetown University Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL).

Is MedStar Georgetown University Medical Center accredited by Crixeo Health?

MedStar Georgetown University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Georgetown University Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.